Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1340158
European Journal of Endocrinology, Vol 134, Issue 2, 158-159
Copyright © 1996 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meier, C. A
Right arrow Search for Related Content
PubMed
Right arrow Articles by Meier, C. A

Co-activators and co-repressors: mediators of gene activation by nuclear hormone receptors

Christoph A Meier

Hormones may act through either membrane-bound or nuclear receptor proteins. Whereas peptide hormones bind to receptors on the cell surface, small lipophilic hormones and vitamins such as steroids, retinoids and l-triiodothyronine enter the cell and bind to their respective intracellular receptor protein. All members of the nuclear hormone receptor superfamily (steroid, vitamin D (VDR), retinoid (RAR, RXR), thyroid (TR) and peroxisome proliferator-activated (PPAR) receptors) exert their action on target genes by binding to short, but specific, regulatory DNA sequences in the promoter region of hormone-regulated genes, thereby increasing or decreasing their transcription rate. However, in contrast to steroid hormone receptors, the RAR, RXR, TR, VDR and PPAR are capable of binding to DNA even in the absence of their cognate ligand. The molecular details of ligand-induced transcriptional activation have remained enigmatic because DNA binding of these unliganded receptors does not increase transcription and in some cases even decreases basal transcription







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 European Society of Endocrinology.